Ian B. Walters, MD

CMO
Intensity Therapeutics
Westport, Connecticut, United States

`

Presentation(s):

• Paper 55 - INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)

  Friday, November 18, 2022
  3:38 PM – 3:46 PM